MedTrace Logo

Longterm Effectiveness of Artificial Intelligence-assisted Colonoscopy on Adenoma Recurrence

NCT06251700 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 775

Last updated 2024-10-29

No results posted yet for this study

Summary

We hypothesize that AI-assisted colonoscopy can reduce post-colonoscopy neoplasia incidence after 3 years, over standard colonoscopy. Moreover, this protective effect may allow surveillance intervals to be lengthened, by modifying long-term outcome of high-risk subgroup.

Conditions

  • Screening Colonscopy

Interventions

DEVICE

ENDO-AID CADe

ENDO-AID CADe will be used during the withdrawal process of the colonscopy

Sponsors & Collaborators

  • Chinese University of Hong Kong

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-24
Primary Completion
2026-12-31
Completion
2027-04-30

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06251700 on ClinicalTrials.gov